欧洲心脏病学会2021年心血管疾病统计报告
该报告更新并扩展了2019年ESC Atlas项目,呈现57个ESC成员国2019年或最新可得年份的心血管疾病统计数据。数据来源包括WHO、IHME、世界银行及ESC资助的新数据,涵盖社会人口与环境决定因素、风湿性心脏病、院外心脏骤停、左心瓣膜病等。报告指出中低收入国家心血管疾病负担更重、医疗资源不足,且多数WHO 2025非传染性疾病目标恐难达成。
要点
- 中收入ESC成员国CVD发病率较高收入国家高约30%,伤残调整生命年高近四倍。
- 2018年高收入国家医疗支出平均为中收入国家的四倍。
- 过去30年钙化性主动脉瓣疾病发病率增加七倍,高收入国家年龄标化率是中收入国家的四倍。
核心结论
- 风险因素和不健康行为潜在可逆,为解决ESC成员国健康不平等提供巨大机会,但现有证据表明努力不足。
- 多数WHO 2025非传染性疾病目标在ESC成员国不太可能实现。
研究设计与样本
- ESC Atlas项目报告,呈现57个ESC成员国2019年或最新可得年份的CVD统计数据。
- 数据来源包括WHO、IHME、世界银行及ESC资助的人力和资本基础设施与心血管医疗服务新数据。
主要发现
- 2018年ESC成员国女性预期寿命80.8年,男性74.8年;高收入国家81.6年,中收入国家74.2年。
- 2019年中收入ESC成员国PM2.5中位浓度较高收入国家高两倍以上,14个国家超过欧盟空气质量标准且均为中收入国家。
- 2016年ESC成员国超过五分之一成年人肥胖,高收入和低收入国家患病率相似;过去35年肥胖患病率增加一倍以上。
- 中收入ESC成员国CVD估计发病率较高收入国家高约30%,CVD所致伤残调整生命年高近四倍。
- 过去30年钙化性主动脉瓣疾病发病率增加七倍,高收入国家年龄标化率是中收入国家的四倍。
临床怎么用
- 心内科医生应关注中收入ESC成员国在冠脉介入、消融、器械植入和心脏手术方面的资源缺口。
- 鉴于肥胖和PM2.5暴露等可逆风险因素负担重,应加强一级预防和危险因素管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) statistics for the 57 ESC member countries. METHODS AND RESULTS: Statistics pertaining to 2019, or the latest available year, are presented. Data sources include the World Health Organization, the Institute for Health Metrics and Evaluation, the World Bank, and novel ESC sponsored data on human and capital infrastructure and cardiovascular healthcare delivery. New material in this report includes sociodemographic and environmental determinants of CVD, rheumatic heart disease, out-of-hospital cardiac arrest, left-sided valvular heart disease, the advocacy potential of these CVD statistics, and progress towards World Health Organization (WHO) 2025 targets for non-communicable diseases. Salient observations in this report: (i) Females born in ESC member countries in 2018 are expected to live 80.8 years and males 74.8 years. Life expectancy is longer in high income (81.6 years) compared with middle-income (74.2 years) countries. (ii) In 2018, high-income countries spent, on average, four times more on healthcare than middle-income countries. (iii) The median PM2.5 concentrations in 2019 were over twice as high in middle-income ESC member countries compared with high-income countries and exceeded the EU air quality standard in 14 countries, all middle-income. (iv) In 2016, more than one in five adults across the ESC member countries were obese with similar prevalence in high and low-income countries. The prevalence of obesity has more than doubled over the past 35 years. (v) The burden of CVD falls hardest on middle-income ESC member countries where estimated incidence rates are ∼30% higher compared with high-income countries. This is reflected in disability-adjusted life years due to CVD which are nearly four times as high in middle-income compared with high-income countries. (vi) The incidence of calcific aortic valve disease has increased seven-fold during the last 30 years, with age-standardized rates four times as high in high-income compared with middle-income countries. (vii) Although the total number of CVD deaths across all countries far exceeds the number of cancer deaths for both sexes, there are 15 ESC member countries in which cancer accounts for more deaths than CVD in males and five-member countries in which cancer accounts for more deaths than CVD in females. (viii) The under-resourced status of middle-income countries is associated with a severe procedural deficit compared with high-income countries in terms of coronary intervention, ablation procedures, device implantation, and cardiac surgical procedures. CONCLUSION: Risk factors and unhealthy behaviours are potentially reversible, and this provides a huge opportunity to address the health inequalities across ESC member countries that are highlighted in this report. It seems clear, however, that efforts to seize this opportunity are falling short and present evidence suggests that most of the WHO NCD targets for 2025 are unlikely to be met across ESC member countries.
引用
- Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022. PMID: 35016208. doi:10.1093/eurheartj/ehab892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。